Bridgeway Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-212,000
| Closed | -$575K | – | 1307 |
|
2024
Q1 | $575K | Hold |
212,000
| – | – | 0.01% | 887 |
|
2023
Q4 | $469K | Hold |
212,000
| – | – | 0.01% | 954 |
|
2023
Q3 | $615K | Hold |
212,000
| – | – | 0.01% | 826 |
|
2023
Q2 | $409K | Hold |
212,000
| – | – | 0.01% | 961 |
|
2023
Q1 | $413K | Hold |
212,000
| – | – | 0.01% | 929 |
|
2022
Q4 | $248K | Buy |
212,000
+50,000
| +31% | +$58.5K | 0.01% | 1030 |
|
2022
Q3 | $178K | Buy |
+162,000
| New | +$178K | ﹤0.01% | 1160 |
|
2019
Q2 | – | Sell |
-54,945
| Closed | -$730K | – | 1359 |
|
2019
Q1 | $730K | Sell |
54,945
-113,627
| -67% | -$1.51M | 0.01% | 875 |
|
2018
Q4 | $1.45M | Hold |
168,572
| – | – | 0.02% | 605 |
|
2018
Q3 | $1.26M | Hold |
168,572
| – | – | 0.01% | 784 |
|
2018
Q2 | $1.01M | Hold |
168,572
| – | – | 0.01% | 875 |
|
2018
Q1 | $984K | Buy |
168,572
+95,000
| +129% | +$555K | 0.01% | 846 |
|
2017
Q4 | $433K | Sell |
73,572
-70,000
| -49% | -$412K | ﹤0.01% | 1140 |
|
2017
Q3 | $724K | Hold |
143,572
| – | – | 0.01% | 968 |
|
2017
Q2 | $580K | Hold |
143,572
| – | – | 0.01% | 1038 |
|
2017
Q1 | $817K | Buy |
+143,572
| New | +$817K | 0.01% | 887 |
|